According to a study funded by the National Pharmaceutical Council, real-world evidence (RWE) is infrequently used in pharmacy and therapeutic (P&T) class reviews and monographs.
After analyzing 565 references cited in 27 monographs and therapeutic class reviews, researchers found therapeutic class reviews cited clinical trials 35 percent of the time; monographs heavily leaned on information supplied by manufacturers in 42 percent of the citations. Monograph references cited no published RWE, but therapeutic class review did reference RWE in 21 instances (4.9 percent).
“Although few P&T materials cited RWE, the comparative RWE studies were generally high quality,” according to the study.
(Source: Journal of Managed Care & Specialty Pharmacy)